M3, Inc. is a Tokyo‐based company specializing in digital healthcare solutions and medical media platforms. Founded in 2000, the firm operates online networks that connect healthcare professionals with pharmaceutical and biotech companies, providing medical information, educational content and peer‐to‐peer communication tools. Over time, M3 has expanded its portfolio to encompass a broad range of services aimed at enhancing clinical decision‐making and streamlining drug development processes.
The company’s offerings include physician portals that deliver the latest research and treatment guidelines, digital marketing and e‐detailing services for life sciences companies, and real‐world evidence (RWE) analytics based on de-identified patient data. M3 also provides clinical trial support, leveraging its extensive practitioner network to facilitate patient recruitment, site management and post-marketing surveillance. Its technology‐driven approach helps clients optimize study design, accelerate timelines and meet regulatory requirements across multiple markets.
With operations spanning Japan, North America, Europe and the Asia-Pacific region, M3 serves a global customer base of healthcare professionals, pharmaceutical companies and medical device manufacturers. The company has established regional hubs in key markets, enabling localized content, market access support and compliance expertise. Its cross‐border infrastructure allows clients to harmonize launch strategies and gather insights on treatment patterns in diverse healthcare systems.
Headquartered in Tokyo and led by President and CEO Tsuyoshi Koizumi, M3 continues to invest in technology and strategic partnerships aimed at driving innovation in digital health. By integrating advanced analytics, artificial intelligence and large‐scale clinician networks, the company seeks to address evolving industry needs and support the development of new therapies worldwide.
AI Generated. May Contain Errors.
Free MTHRF Stock Alerts